Effect of catheter ablation and periprocedural anticoagulation regimen on the clinical course of migraine in atrial fibrillation patients with or without pre-existent migraine

Sanghamitra Mohanty, Prasant Mohanty, J. Neal Rutledge, Luigi Di Biase, Rachel Xue Yan, Chintan Trivedi, Pasquale Santangeli, Rong Bai, Deb Cardinal, J. David Burkhardt, Joseph G. Gallinghouse, Rodney Horton, Javier E. Sanchez, Shane Bailey, Patrick M. Hranitzky, Jason Zagrodzky, Amin Al-Ahmad, Andrea Natale

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background-We examined the influence of catheter ablation and periprocedural anticoagulation regimen on trajectory of migraine in atrial fibrillation patients with or without migraine history. Methods and Results-Forty patients with (group 1: 64±8 years; men 78%) and 85 (group 2: 61±10 years; men 73%) without migraine history undergoing atrial fibrillation-ablation were enrolled. Migraine status and quality of life were evaluated using standardized questionnaires. Diffusion magnetic resonance imaging of brain was performed for all at pre and 24 hours post procedure. Catheter ablation was performed with (88, 70%) or without (37, 30%) continuous warfarin treatment. Fifty-four patients (11 and 43 from groups 1 and 2, respectively) had subtherapeutic international normalized ratio on procedure day. At 17±5 months follow-up, from group 1, 25 (63%) reported no migraine, 10 (25%) had <1, and 3 (8%) had 2 to 3 monthly symptoms. Intensity of pain decreased from baseline 7 (Q1-Q3, 4-8) to 2 (0-4) scale points at follow-up (P<0.001) and duration of headache from median 8 (Q1-Q3, 4-15) to 0.5 (Q1-Q3, 0-2) hours (P<0.001). Two patients from group 1 reported increased migraine severity and 2 from group 2 had new-onset migraine. Follow-up diffusion magnetic resonance imaging revealed new infarcts in 9.6% (12/125) patients; of which 11 had subtherapeutic preprocedural international normalized ratio on or off continuous warfarin. Quality of life improved significantly in patients with successful ablation, being more pronounced in group 1. Conclusions-In most patients, migraine symptoms improved substantially after catheter ablation. Interestingly, the only cases of new migraine and aggravation of pre-existent headache had subtherapeutic international normalized ratio during the procedure and new cerebral infarcts.

Original languageEnglish (US)
Pages (from-to)279-287
Number of pages9
JournalCirculation: Arrhythmia and Electrophysiology
Volume8
Issue number2
DOIs
StatePublished - Apr 20 2015

Fingerprint

Catheter Ablation
Migraine Disorders
Atrial Fibrillation
International Normalized Ratio
Diffusion Magnetic Resonance Imaging
Warfarin
Headache
Quality of Life
Pain
Brain

Keywords

  • atrial fibrillation
  • catheter ablation
  • diffusion MRI
  • migraine disorders

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)
  • Medicine(all)

Cite this

Effect of catheter ablation and periprocedural anticoagulation regimen on the clinical course of migraine in atrial fibrillation patients with or without pre-existent migraine. / Mohanty, Sanghamitra; Mohanty, Prasant; Rutledge, J. Neal; Di Biase, Luigi; Yan, Rachel Xue; Trivedi, Chintan; Santangeli, Pasquale; Bai, Rong; Cardinal, Deb; Burkhardt, J. David; Gallinghouse, Joseph G.; Horton, Rodney; Sanchez, Javier E.; Bailey, Shane; Hranitzky, Patrick M.; Zagrodzky, Jason; Al-Ahmad, Amin; Natale, Andrea.

In: Circulation: Arrhythmia and Electrophysiology, Vol. 8, No. 2, 20.04.2015, p. 279-287.

Research output: Contribution to journalArticle

Mohanty, S, Mohanty, P, Rutledge, JN, Di Biase, L, Yan, RX, Trivedi, C, Santangeli, P, Bai, R, Cardinal, D, Burkhardt, JD, Gallinghouse, JG, Horton, R, Sanchez, JE, Bailey, S, Hranitzky, PM, Zagrodzky, J, Al-Ahmad, A & Natale, A 2015, 'Effect of catheter ablation and periprocedural anticoagulation regimen on the clinical course of migraine in atrial fibrillation patients with or without pre-existent migraine', Circulation: Arrhythmia and Electrophysiology, vol. 8, no. 2, pp. 279-287. https://doi.org/10.1161/CIRCEP.114.002285
Mohanty, Sanghamitra ; Mohanty, Prasant ; Rutledge, J. Neal ; Di Biase, Luigi ; Yan, Rachel Xue ; Trivedi, Chintan ; Santangeli, Pasquale ; Bai, Rong ; Cardinal, Deb ; Burkhardt, J. David ; Gallinghouse, Joseph G. ; Horton, Rodney ; Sanchez, Javier E. ; Bailey, Shane ; Hranitzky, Patrick M. ; Zagrodzky, Jason ; Al-Ahmad, Amin ; Natale, Andrea. / Effect of catheter ablation and periprocedural anticoagulation regimen on the clinical course of migraine in atrial fibrillation patients with or without pre-existent migraine. In: Circulation: Arrhythmia and Electrophysiology. 2015 ; Vol. 8, No. 2. pp. 279-287.
@article{0df1025e7d364cab9d4fda2f6732b123,
title = "Effect of catheter ablation and periprocedural anticoagulation regimen on the clinical course of migraine in atrial fibrillation patients with or without pre-existent migraine",
abstract = "Background-We examined the influence of catheter ablation and periprocedural anticoagulation regimen on trajectory of migraine in atrial fibrillation patients with or without migraine history. Methods and Results-Forty patients with (group 1: 64±8 years; men 78{\%}) and 85 (group 2: 61±10 years; men 73{\%}) without migraine history undergoing atrial fibrillation-ablation were enrolled. Migraine status and quality of life were evaluated using standardized questionnaires. Diffusion magnetic resonance imaging of brain was performed for all at pre and 24 hours post procedure. Catheter ablation was performed with (88, 70{\%}) or without (37, 30{\%}) continuous warfarin treatment. Fifty-four patients (11 and 43 from groups 1 and 2, respectively) had subtherapeutic international normalized ratio on procedure day. At 17±5 months follow-up, from group 1, 25 (63{\%}) reported no migraine, 10 (25{\%}) had <1, and 3 (8{\%}) had 2 to 3 monthly symptoms. Intensity of pain decreased from baseline 7 (Q1-Q3, 4-8) to 2 (0-4) scale points at follow-up (P<0.001) and duration of headache from median 8 (Q1-Q3, 4-15) to 0.5 (Q1-Q3, 0-2) hours (P<0.001). Two patients from group 1 reported increased migraine severity and 2 from group 2 had new-onset migraine. Follow-up diffusion magnetic resonance imaging revealed new infarcts in 9.6{\%} (12/125) patients; of which 11 had subtherapeutic preprocedural international normalized ratio on or off continuous warfarin. Quality of life improved significantly in patients with successful ablation, being more pronounced in group 1. Conclusions-In most patients, migraine symptoms improved substantially after catheter ablation. Interestingly, the only cases of new migraine and aggravation of pre-existent headache had subtherapeutic international normalized ratio during the procedure and new cerebral infarcts.",
keywords = "atrial fibrillation, catheter ablation, diffusion MRI, migraine disorders",
author = "Sanghamitra Mohanty and Prasant Mohanty and Rutledge, {J. Neal} and {Di Biase}, Luigi and Yan, {Rachel Xue} and Chintan Trivedi and Pasquale Santangeli and Rong Bai and Deb Cardinal and Burkhardt, {J. David} and Gallinghouse, {Joseph G.} and Rodney Horton and Sanchez, {Javier E.} and Shane Bailey and Hranitzky, {Patrick M.} and Jason Zagrodzky and Amin Al-Ahmad and Andrea Natale",
year = "2015",
month = "4",
day = "20",
doi = "10.1161/CIRCEP.114.002285",
language = "English (US)",
volume = "8",
pages = "279--287",
journal = "Circulation: Arrhythmia and Electrophysiology",
issn = "1941-3149",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Effect of catheter ablation and periprocedural anticoagulation regimen on the clinical course of migraine in atrial fibrillation patients with or without pre-existent migraine

AU - Mohanty, Sanghamitra

AU - Mohanty, Prasant

AU - Rutledge, J. Neal

AU - Di Biase, Luigi

AU - Yan, Rachel Xue

AU - Trivedi, Chintan

AU - Santangeli, Pasquale

AU - Bai, Rong

AU - Cardinal, Deb

AU - Burkhardt, J. David

AU - Gallinghouse, Joseph G.

AU - Horton, Rodney

AU - Sanchez, Javier E.

AU - Bailey, Shane

AU - Hranitzky, Patrick M.

AU - Zagrodzky, Jason

AU - Al-Ahmad, Amin

AU - Natale, Andrea

PY - 2015/4/20

Y1 - 2015/4/20

N2 - Background-We examined the influence of catheter ablation and periprocedural anticoagulation regimen on trajectory of migraine in atrial fibrillation patients with or without migraine history. Methods and Results-Forty patients with (group 1: 64±8 years; men 78%) and 85 (group 2: 61±10 years; men 73%) without migraine history undergoing atrial fibrillation-ablation were enrolled. Migraine status and quality of life were evaluated using standardized questionnaires. Diffusion magnetic resonance imaging of brain was performed for all at pre and 24 hours post procedure. Catheter ablation was performed with (88, 70%) or without (37, 30%) continuous warfarin treatment. Fifty-four patients (11 and 43 from groups 1 and 2, respectively) had subtherapeutic international normalized ratio on procedure day. At 17±5 months follow-up, from group 1, 25 (63%) reported no migraine, 10 (25%) had <1, and 3 (8%) had 2 to 3 monthly symptoms. Intensity of pain decreased from baseline 7 (Q1-Q3, 4-8) to 2 (0-4) scale points at follow-up (P<0.001) and duration of headache from median 8 (Q1-Q3, 4-15) to 0.5 (Q1-Q3, 0-2) hours (P<0.001). Two patients from group 1 reported increased migraine severity and 2 from group 2 had new-onset migraine. Follow-up diffusion magnetic resonance imaging revealed new infarcts in 9.6% (12/125) patients; of which 11 had subtherapeutic preprocedural international normalized ratio on or off continuous warfarin. Quality of life improved significantly in patients with successful ablation, being more pronounced in group 1. Conclusions-In most patients, migraine symptoms improved substantially after catheter ablation. Interestingly, the only cases of new migraine and aggravation of pre-existent headache had subtherapeutic international normalized ratio during the procedure and new cerebral infarcts.

AB - Background-We examined the influence of catheter ablation and periprocedural anticoagulation regimen on trajectory of migraine in atrial fibrillation patients with or without migraine history. Methods and Results-Forty patients with (group 1: 64±8 years; men 78%) and 85 (group 2: 61±10 years; men 73%) without migraine history undergoing atrial fibrillation-ablation were enrolled. Migraine status and quality of life were evaluated using standardized questionnaires. Diffusion magnetic resonance imaging of brain was performed for all at pre and 24 hours post procedure. Catheter ablation was performed with (88, 70%) or without (37, 30%) continuous warfarin treatment. Fifty-four patients (11 and 43 from groups 1 and 2, respectively) had subtherapeutic international normalized ratio on procedure day. At 17±5 months follow-up, from group 1, 25 (63%) reported no migraine, 10 (25%) had <1, and 3 (8%) had 2 to 3 monthly symptoms. Intensity of pain decreased from baseline 7 (Q1-Q3, 4-8) to 2 (0-4) scale points at follow-up (P<0.001) and duration of headache from median 8 (Q1-Q3, 4-15) to 0.5 (Q1-Q3, 0-2) hours (P<0.001). Two patients from group 1 reported increased migraine severity and 2 from group 2 had new-onset migraine. Follow-up diffusion magnetic resonance imaging revealed new infarcts in 9.6% (12/125) patients; of which 11 had subtherapeutic preprocedural international normalized ratio on or off continuous warfarin. Quality of life improved significantly in patients with successful ablation, being more pronounced in group 1. Conclusions-In most patients, migraine symptoms improved substantially after catheter ablation. Interestingly, the only cases of new migraine and aggravation of pre-existent headache had subtherapeutic international normalized ratio during the procedure and new cerebral infarcts.

KW - atrial fibrillation

KW - catheter ablation

KW - diffusion MRI

KW - migraine disorders

UR - http://www.scopus.com/inward/record.url?scp=84932184231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84932184231&partnerID=8YFLogxK

U2 - 10.1161/CIRCEP.114.002285

DO - 10.1161/CIRCEP.114.002285

M3 - Article

C2 - 25682124

AN - SCOPUS:84932184231

VL - 8

SP - 279

EP - 287

JO - Circulation: Arrhythmia and Electrophysiology

JF - Circulation: Arrhythmia and Electrophysiology

SN - 1941-3149

IS - 2

ER -